Literature DB >> 18385819

The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function.

Felix Fleissner1, Thomas Thum.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18385819      PMCID： PMC2277320          DOI： 10.2119/2008-00037.Fleissner

Source DB:  PubMed          Journal:  Mol Med        ISSN： 1076-1551            Impact factor:   6.354


× No keyword cloud information.
  16 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.

Authors:  Thomas Thum; Dimitrios Tsikas; Sylvia Stein; Maximilian Schultheiss; Martin Eigenthaler; Stefan D Anker; Philip A Poole-Wilson; Georg Ertl; Johann Bauersachs
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

3.  Circulating endothelial progenitor cells and cardiovascular outcomes.

Authors:  Nikos Werner; Sonja Kosiol; Tobias Schiegl; Patrick Ahlers; Katrin Walenta; Andreas Link; Michael Böhm; Georg Nickenig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

4.  Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.

Authors:  R H Böger; C Skamira; S M Bode-Böger; G Brabant; A von zur Muhlen; J C Frolich
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

5.  N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Christian W Hamm; Veselin Mitrovic; Nicte-Ha Lantelme; Harvey D White
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

6.  Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

Authors:  P Kurtzhals; L Schäffer; A Sørensen; C Kristensen; I Jonassen; C Schmid; T Trüb
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

7.  Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.

Authors:  Thomas Thum; Sarah Hoeber; Sabrina Froese; Ivonne Klink; Dirk O Stichtenoth; Paolo Galuppo; Marten Jakob; Dimitrios Tsikas; Stefan D Anker; Philip A Poole-Wilson; Jürgen Borlak; Georg Ertl; Johann Bauersachs
Journal:  Circ Res       Date:  2007-01-18       Impact factor: 17.367

8.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.

Authors:  Alexandra Aicher; Christopher Heeschen; Christiane Mildner-Rihm; Carmen Urbich; Christian Ihling; Katja Technau-Ihling; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Nat Med       Date:  2003-10-12       Impact factor: 53.440

9.  Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.

Authors:  Björn Ellger; Milan C Richir; Paul A M van Leeuwen; Yves Debaveye; Lies Langouche; Ilse Vanhorebeek; Tom Teerlink; Greet Van den Berghe
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

10.  Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.

Authors:  Beate Heissig; Koichi Hattori; Sergio Dias; Matthias Friedrich; Barbara Ferris; Neil R Hackett; Ronald G Crystal; Peter Besmer; David Lyden; Malcolm A S Moore; Zena Werb; Shahin Rafii
Journal:  Cell       Date:  2002-05-31       Impact factor: 41.582
View more
  7 in total

1.  Protective role of insulin-like growth factor-1 receptor in endothelial cells against unilateral ureteral obstruction-induced renal fibrosis.

Authors:  Ming Liang; Lauren E Woodard; Anlin Liang; Jinlong Luo; Matthew H Wilson; William E Mitch; Jizhong Cheng
Journal:  Am J Pathol       Date:  2015-03-14       Impact factor: 4.307

Review 2.  Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.

Authors:  Felix Fleissner; Thomas Thum
Journal:  Antioxid Redox Signal       Date:  2010-12-13       Impact factor: 8.401

3.  Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice.

Authors:  Daniel Barthelmes; Ling Zhu; Weiyong Shen; Mark C Gillies; Mohammad R Irhimeh
Journal:  Cardiovasc Diabetol       Date:  2014-02-12       Impact factor: 9.951

4.  Synergism of matrix stiffness and vascular endothelial growth factor on mesenchymal stem cells for vascular endothelial regeneration.

Authors:  Kathryn Wingate; Michael Floren; Yan Tan; Pi Ou Nancy Tseng; Wei Tan
Journal:  Tissue Eng Part A       Date:  2014-05-09       Impact factor: 3.845

5.  Particle Radiation-Induced Nontargeted Effects in Bone-Marrow-Derived Endothelial Progenitor Cells.

Authors:  Sharath P Sasi; Daniel Park; Sujatha Muralidharan; Justin Wage; Albert Kiladjian; Jillian Onufrak; Heiko Enderling; Xinhua Yan; David A Goukassian
Journal:  Stem Cells Int       Date:  2015-05-05       Impact factor: 5.443

Review 6.  Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.

Authors:  Hyunyun Kim; Sujin Kim; Sang Hong Baek; Sang-Mo Kwon
Journal:  Stem Cells Int       Date:  2016-12-20       Impact factor: 5.443

7.  Platelets of Healthy Origins Promote Functional Improvement of Atherosclerotic Endothelial Progenitor Cells.

Authors:  Nicoleta Alexandru; Florentina Safciuc; Alina Constantin; Miruna Nemecz; Gabriela Tanko; Alexandru Filippi; Emanuel Dragan; Elisabeta Bãdilã; Adriana Georgescu
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.